Aiming for Worldwide Sales & Distribution
The main market of our ReBOSSIS [cottony-type, synthetic bone-void-filling material] is the United States of America. Since the initial start of the sales back in February 2015, ReBOSSIS has been widely utilized in orthopedic surgeries in the field of trauma and spine. A great number of doctors have given our ReBOSSIS a highly good evaluation since ReBOSSIS is easy to use and has a high-level bone neoplasia.
As for other overseas markets, we have obtained approval to sell ReBOSSIS both in Taiwan and India in 2020, and here in Japan, our home country, we have obtained PMDA approval in March 2021 under the name of ReBOSSIS-J, and have started the sales in Japan from September 2021.
We plan to sell and distribute ReBOSSIS in Europe, East Europe, Russia. Especially, we are preparing to obtain CE Marking Certification in order that ReBOSSIS can be promoted and sold in Europe, the largest market among them.